Clinical Centre of Kragujevac

Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease

Bernard De Bruyne, Nico H.J. Pijls, Bindu Kalesan et al. · New England Journal of Medicine · 2012 · 2.7K citations · Full text

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Jeffrey Cohen, Alasdair Coles, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations

Rheumatology, Relapsing-remitting Multiple Sclerosis, Immunology +8

Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease

Bernard De Bruyne, William F. Fearon, Nico H.J. Pijls et al. · New England Journal of Medicine · 2014 · 1K citations · Full text

Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

Panagiotis Xaplanteris, Stéphane Fournier, Nico H.J. Pijls et al. · New England Journal of Medicine · 2018 · 837 citations · Full text

Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?

Dragan Djordjević, Goran Rondović, Maja Šurbatović et al. · Mediators of Inflammation · 2018 · 259 citations · Full text